Anebulo Pharmaceuticals (ANEB) Interest & Investment Income (2022 - 2025)
Anebulo Pharmaceuticals' Interest & Investment Income came in at $85,410 for fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with $7,067 a year earlier and down 22.1% from the prior quarter.
Anebulo Pharmaceuticals (ANEB) Interest & Investment Income (2022 - 2025) Analysis & Trends
Over the trailing twelve months to Dec 31, 2025, Anebulo Pharmaceuticals reported Interest & Investment Income of $419,866, up 177.4% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $257,913, up 3.6% from FY2024.
- Interest & Investment Income carries a four-year compound annual growth rate of 298.8% (FY2021 to FY2025).
- Going back by fiscal year, Interest & Investment Income was $249,022 in FY2024 (+169.5%), $92,407 in FY2023, $7,332 in FY2022 (+618.8%) and $1,020 in FY2021.
- The five-year range for quarterly Interest & Investment Income is $6.00 (fiscal Q4 2023) to $122,583 (fiscal Q4 2025).
- Year-over-year, Interest & Investment Income increased in three of the last six quarters, with growth averaging 59.7%.
- Business Quant data shows ANEB's Interest & Investment Income at $109,616 (Q1 2026), $122,583 (Q4 2025) and $102,257 (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 85,410.00 |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 85,410.00 |
| Sep 30, 2025 | 109,616.00 |
| Jun 30, 2025 | 122,583.00 |
| Mar 31, 2025 | 102,257.00 |
| Dec 31, 2024 | 7,067.00 |
| Sep 30, 2024 | 26,006.00 |
| Jun 30, 2024 | 50,218.00 |
| Mar 31, 2024 | 68,084.00 |
| Dec 31, 2023 | 75,522.00 |
| Sep 30, 2023 | 55,198.00 |
| Jun 30, 2023 | 6.00 |
| Mar 31, 2023 | 79,152.00 |
| Dec 31, 2022 | 8,816.00 |
Anebulo Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();